13G Filing: Deerfield Management Reveals 5% Stake in Newly-Public Editas Medicine, Inc. (EDIT)

Page 10 of 13

Page 10 of 13 SEC Filing

CUSIP No.
28106W103
13G
Page 11 of 11
                                    
SIGNATURE
 
     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
DEERFIELD MGMT HIF, L.P.
 
By:  J.E. Flynn Capital HIF, LLC, General Partner
 
By: /s/ Jonathan Isler
       Jonathan Isler, Attorney-In-Fact
 
 
DEERFIELD MANAGEMENT COMPANY, L.P.
 
By: Flynn Management LLC, General Partner
 
By: /s/ Jonathan Isler
       Jonathan Isler, Attorney-In-Fact
 
 
DEERFIELD MGMT III, L.P.
 
By: J.E. Flynn Capital III, LLC, General Partner
 
By: /s/ Jonathan Isler
       Jonathan Isler, Attorney-In-Fact
 
 
DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.
 
By:  Deerfield Mgmt HIF, L.P., General Partner
 
By:  J.E. Flynn Capital HIF, LLC, General Partner
 
By: /s/ Jonathan Isler
       Jonathan Isler, Attorney-In-Fact
 
 
DEERFIELD PRIVATE DESIGN FUND III, L.P.
 
By: Deerfield Mgmt III, L.P., General Partner
 
By: J.E. Flynn Capital III, LLC, General Partner
 
By: /s/ Jonathan Isler
       Jonathan Isler, Attorney-In-Fact
 
 
JAMES E. FLYNN
 
/s/ Jonathan Isler
Jonathan Isler, Attorney-In-Fact
 
Date:  February 8, 2016
 

Follow Editas Medicine Inc.

Page 10 of 13